o
|
|
Preliminary
Proxy Statement
|
|
¨
|
|
Confidential,
for Use of the Commission
Only (as
permitted by Rule 14a-6(e)(2))
|
x
|
|
Definitive
Proxy Statement
|
|
|
||
¨
|
|
Definitive
Additional Materials
|
|
|
||
¨
|
|
Soliciting
Material Pursuant to §240.14a-12
|
|
|
x
|
|
No
fee required.
|
o
|
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
(1)
|
|
Title
of each class of securities to which transaction applies:
|
|
(2)
|
|
Aggregate
number of securities to which transaction applies:
|
|
(3)
|
|
Per
unit price or other underlying value of transaction computed pursuant
to
Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is
calculated and state how it was determined):
|
|
(4)
|
|
Proposed
maximum aggregate value of transaction:
|
|
(5)
|
|
Total
fee paid:
|
o
|
|
Fee
paid previously with preliminary materials.
|
o
|
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule
0-11(a)(2) and identify the filing for which the offsetting fee was
paid
previously. Identify the previous filing by registration statement
number,
or the Form or Schedule and the date of its filing.
|
|
(1)
|
|
Amount
Previously Paid:
|
|
(2)
|
|
Form,
Schedule or Registration Statement No.:
|
|
(3)
|
|
Filing
Party:
|
|
(4)
|
|
Date
Filed:
|
|
|
By
Order of the Board of Directors
|
|
|
|
August
10,
2006
|
|
GREGORY
A. FRASER, Ph.D.
|
|
|
Executive
Vice President
|
·
|
Jay
Freeland - two year term until 2008
|
·
|
Simon
Raab - three year term until 2009
|
·
|
Andre
Julien - three year term until 2009
|
·
|
Hubert
d’Amours - three year term until
2009
|
·
|
For
election of the nominated slate of directors (see Item
1)
|
Nominees
for Election at the Annual Meeting
|
||||||||||
Name
|
Age
|
Director
Since
|
Term
Expires
|
|||||||
Jay
Freeland
|
36
|
2006
|
2008
|
|||||||
Simon
Raab
|
53
|
1982
|
2009
|
|||||||
Andre
Julien
Operational
Audit, Nominating, and Compensation Committees
|
62
|
1986
|
2009
|
|||||||
Hubert
d’Amours
Audit,
Nominating, and Compensation Committees
|
67
|
1990
|
2009
|
Name
|
Age
|
Director
Since
|
Term
Expires
|
|||||||
Gregory
A. Fraser
|
51
|
1982
|
2008
|
|||||||
Stephen
R. Cole
Audit,
Nominating, and Compensation Committees
|
53
|
2002
|
2008
|
|||||||
John
Caldwell
Audit,
Operational
Audit, Nominating, and Compensation Committees
|
56
|
2002
|
2007
|
|||||||
Norman
Schipper, Q.C.
Nominating
and Compensation
Committees
|
75
|
1982
|
2007
|
·
|
Chairs
the executive sessions of the independent
directors;
|
·
|
Advises
the Chairman on the schedule and agenda for Board meetings and other
matters pertinent to the Company;
|
·
|
Serves
as a liaison between non-management directors and the Company’s
management.
|
·
|
Each
director must display high personal and professional ethics, integrity
and
values.
|
·
|
Each
director must have the ability to exercise sound business
judgment.
|
·
|
Each
director must be highly accomplished in his or her respective field,
with
broad experience at the administrative and/or policy-making level
in
business, government, education, technology or public
interest.
|
·
|
Each
director must have relevant expertise and experience, and be able
to offer
advice and guidance based on that expertise and
experience.
|
·
|
Each
director must be independent of any particular constituency, be able
to
represent all shareholders of the Company and be committed to enhancing
long-term shareholder value.
|
·
|
Each
director must have sufficient time available to devote to activities
of
the Board and to enhance his or her knowledge of the Company’s business.
|
·
|
The
Nominating Committee also believes the following qualities or skills
are
necessary for one or more directors to
possess:
|
·
|
One or more of the directors generally should be active or former chief executive officers of public or private companies or leaders of major organizations, including commercial, scientific, government, educational and other similar institutions. |
·
|
Directors should be selected so that the Board is a diverse body. |
Name
of Beneficial Owner
|
Number
of
Shares
|
Percent
|
|||||
Simon
Raab, Ph.D.(1)
|
1,250,552
|
8.6
|
%
|
||||
Jay
Freeland (2)
|
95,040
|
*
|
|||||
Gregory
A. Fraser, Ph.D.(3)
|
181,785
|
1.2
|
%
|
||||
Barbara
R. Smith (4)
|
71,373
|
*
|
|||||
Hubert
d’Amours (5)
|
18,702
|
*
|
|||||
Andre
Julien (6)
|
53,307
|
*
|
|||||
Norman
H. Schipper, Q.C.(7)
|
8,267
|
*
|
|||||
Stephen
R. Cole (8)
|
14,249
|
*
|
|||||
John
Caldwell (9)
|
9,841
|
*
|
|||||
FMR
Corp. (10)
|
2,168,793
|
14.9
|
%
|
||||
Ronald
J. Juvonen
Downtown
Associates, LLC (11)
|
1,400,000
|
9.6
|
%
|
||||
Franklin
Advisors, Inc. (12)
|
1,173,505
|
8.1
|
%
|
||||
Lazard
Asset Management (US) (13)
|
845,794
|
5.8
|
%
|
||||
Gerald
Catenacci
Principled
Asset Management LLC (14)
|
740,300
|
5.1
|
%
|
||||
Sovereign
Asset Management Corp. (15)
|
737,300
|
5.1
|
%
|
||||
All
directors and executive officers as a group (9 persons)
|
1,703,116
|
11.4
|
%
|
*
|
Represents
less than one percent of the Company’s outstanding Common Stock.
|
(1)
|
Includes
944,031 shares held by Xenon Research, Inc. (“Xenon”), which is owned by
Mr. Raab and his spouse, and an option to purchase 90,000 shares
at $2.23
per share that is currently exercisable.
|
(2)
|
Includes
options to purchase (i) 50,000 shares at $24.35 per share and (ii)
40,000
shares at $19.38 per share that are currently exercisable.
|
(3)
|
Includes
options to purchase (i) 60,000 shares at $2.16 per share and (ii)
37,600
shares at $19.38 per share that are currently exercisable.
|
(4)
|
Includes
options to purchase (i) 39,000 shares at $26.68 per share and (ii)
30,000
shares at $19.38 per share that are currently
exercisable.
|
(5)
|
Includes
options to purchase (i) 3,000 shares at $3.13 per share, (ii) 3,000
shares
at $2.57 per share, (iii) 3,000 shares at $2.46 per share, (iv) 3,000
shares at $4.42 per share, and (v) 2,000 shares at $21.56 per share
that
are currently exercisable. Does not include an option to purchase
1,000
shares at $21.56 per share that is not exercisable currently or within
the
next 60 days or 1,333 restricted shares of common stock that have
not
vested or will not vest within the next 60
days.
|
(6)
|
Includes
options to purchase (i) 3,000 shares at $4.88 per share, (ii) 3,000
shares
at $3.13 per share, (iii) 3,000 shares at $2.57 per share, (iv) 24,000
shares at $2.49 per share, (v) 3,000 shares at $4.42 per share, and
(vi)
2,000 shares at $21.56 per share that are currently exercisable.
Does not
include an option to purchase 1,000 shares at $21.56 per share that
is not
exercisable currently or within the next 60 days or 1,333 restricted
shares of common stock that have not vested or will not vest within
the
next 60 days.
|
(7)
|
Includes
options to purchase (i) 2,000 shares at $2.21 per share, (ii) 3,000
shares
at $4.42 per share, and (iii) 2,000 shares at $21.56 that are currently
exercisable. Does not include an option to purchase 1,000 shares
at $21.56
per share that is not exercisable currently or within the next 60
days or
1,333 restricted shares of common stock that have not vested or will
not
vest within the next 60 days.
|
(8)
|
Includes
options to purchase (i) 3,000 shares at $2.57 per share, (ii) 3,000
shares
at $4.42 per share, and (iii) 2,000 shares at $21.56 per share that
are
currently exercisable. Does not include an option to purchase 1,000
shares
at $21.56 per share that is not exercisable currently or within the
next
60 days or 1,333 restricted shares of common stock that have not
vested or
will not vest within the next 60 days.
|
(9)
|
Includes
options to purchase (i) 3,000 shares at $1.61 per share, (ii) 3,000
shares
at $4.42 per share, and (iii) 2,000 shares at $21.56 per share that
are
currently exercisable. Does not include an option to purchase 1,000
shares
at $21.56 per share that is not exercisable currently or within the
next
60 days or 1,333 restricted shares of common stock that have not
vested or
will not vest within the next 60 days.
|
(10)
|
This
information as to the beneficial ownership of shares of the Company’s
common stock is based on the February 14, 2006 Scheduled 13G/A filed
with
the Securities and Exchange Commission by such shareholder. The filing
indicates that such shareholder has sole voting and dispositive power
with
respect to all such shares as indicated as follows.
Fidelity
Management & Research Company (“Fidelity”), 82 Devonshire Street,
Boston, Massachusetts 02109, a wholly-owned subsidiary of FMR Corp.
and an
investment adviser registered under Section 203 of the Investment
Advisers
Act of 1940, is the beneficial owner of 2,070,393 shares of the Company’s
common stock as a result of acting as investment adviser to various
investment companies.
Fidelity
Management Trust Company, 82 Devonshire Street, Boston, Massachusetts
02109, a wholly-owned subsidiary of FMR Corp. is the beneficial owner
of
98,400 shares of the Company’s common stock as a result of its serving as
investment manager of various institutional accounts.
Edward
C. John 3d and FMR Corp., through its control of Fidelity Management
Trust
Company, and various Fidelity investment companies that hold shares
of the
Company’s common stock, each has sole power to dispose of 2,168,793 shares
of the Company’s common stock.
|
(11)
|
This
information as to the beneficial ownership of shares of the Company’s
common stock is based on the March 27, 2006 Scheduled 13G filed with
the
Securities and Exchange Commission by such shareholder. The filing
indicates that such shareholder has sole voting and dispositive power
with
respect to all such shares as indicated as follows.
The
shares of the Company’s common stock are held by Downtown Associates I,
L.P., Downtown Associates II, L.P., Downtown Associates III, L.P.,
Downtown Associates IV, L.P. and Downtown Associates V, L.P. (collectively
referred to as the “Downtown Funds”). The general partner of the Downtown
Funds is Downtown Associates, L.L.C. (the “General Partner”). Ronald J.
Juvonen, as the Managing Member of the General Partner, and has sole
power
to vote and direct the disposition of 1,400,000 shares of the Company’s
common stock held by the Downtown Funds.
|
(12)
|
This
information as to the beneficial ownership of shares of the Company’s
common stock is based on the May 11, 2006 Form 13F-HR filed with
the
Securities and Exchange Commission by such institution. The filing
indicates that such institution, by and through its institutional
investment manager(s), has sole voting and dispositive power with
respect
to 1,173,505 shares of Company’s common
stock.
|
(13)
|
This
information as to the beneficial ownership of shares of the Company’s
common stock is based on the July 19, 2006 Form 13F-HR filed with
the
Securities and Exchange Commission by such institution. The filing
indicates that such institution, by and through its institutional
investment manager(s), has sole voting and dispositive power with
respect
to 845,794 shares of Company’s common stock.
|
(14)
|
This
information as to the beneficial ownership of shares of the Company’s
common stock is based on the March 27, 2006 Scheduled 13G filed with
the
Securities and Exchange Commission by such shareholder. Such filing
indicates that such shareholder has sole voting and dispositive power
with
respect to all such shares as indicated as follows
Gerald
Catenacci is the Managing Member of Principled Capital Management,
L.L.C.,
the general partner of each of Highway Partners, L.P. and Thruway
Partners, L.P. Mr. Catenacci is also the Managing Member of Principled
Asset Administration, LLC, the investment advisor to Expressway Partners,
Ltd. Accordingly, Mr. Catenacci is deemed to control 740,300 shares
of the
Company’s common stock beneficially owned by these entities.
|
(15)
|
This
information as to the beneficial ownership of shares of the Company’s
common stock is based on the May 16, 2006 Form 13F-HR filed with
the
Securities and Exchange Commission by such institution. The filing
indicates that such institution, by and through its institutional
investment manager(s), has sole voting and dispositive power with
respect
to 737,300 shares of Company’s common
stock.
|
Name
|
Age
|
Principal
Position
|
Keith
Bair
|
50
|
Interim
Chief Financial Officer
|
Robert
P. Large
|
56
|
Senior
Vice President and Managing Director of FARO
Asia/Pacific
|
Siegfried
K. Buss
|
40
|
Senior
Vice President and Managing
Director of FARO Europe
|
Allen
Sajedi
|
46
|
Vice
President and Chief
Technical Officer
|
|
Annual
Compensation
|
Long-Term
Compensation
|
|
||||||||||||||||||||||
Name and Positions
|
Year
|
Salary
|
Bonus(3)
|
Other
Annual Compensation
|
|
Shares
Underlying Options Granted
|
All
Other Compensation
|
||||||||||||||||||
Simon Raab
|
2005
|
$
|
398,077
|
$
|
79,615
|
—
|
—
|
—
|
|||||||||||||||||
Co-Chief
Executive Officer,
|
2004
|
$
|
347,644
|
$
|
200,000
|
—
|
—
|
—
|
|||||||||||||||||
Chairman
|
2003
|
$
|
288,000
|
$
|
200,000
|
—
|
—
|
—
|
|||||||||||||||||
Jay
Freeland(1)
|
2005
|
$
|
238,492
|
$
|
48,187
|
—
|
40,000
|
—
|
|||||||||||||||||
Co-Chief
Executive Officer,
|
2004
|
$
|
22,115
|
$
|
—
|
—
|
50,000
|
—
|
|||||||||||||||||
President
|
2003
|
$
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||
Barbara
R. Smith(2)
|
2005
|
$
|
169,519
|
$
|
28,038
|
—
|
69,000
|
—
|
|||||||||||||||||
Chief
Financial Officer
|
2004
|
$
|
—
|
$
|
—
|
—
|
—
|
||||||||||||||||||
and
SeniorVice
President
|
2003
|
$
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||
|
|||||||||||||||||||||||||
Gregory
A. Fraser
|
2005
|
$
|
234,423
|
$
|
46,885
|
—
|
37,600
|
—
|
|||||||||||||||||
Executive
Vice President
|
2004
|
$
|
218,969
|
$
|
110,000
|
—
|
—
|
—
|
|||||||||||||||||
2003
|
$
|
193,000
|
$
|
125,000
|
—
|
—
|
—
|
Individual
Grants
|
Potential
Realizable
Value
at Assumed Annual
Rates
of Stock Price
Appreciation
for Option
Term
|
||||||||||||||||||||||||||
Number
of
Securities
Underlying Options Granted (#)
|
Percentage
of Total Options Granted to Employees in 2005
|
Exercise
of Base Price ($/Share)
|
Market
Price of Underlying Security on Date of Grant
|
Expiration
Date
|
5%
($)
|
10%
($)
|
|||||||||||||||||||||
Jay
Freeland
|
40,000
|
12.73
|
19.38
|
19.38
|
12/05/2015
|
487,519
|
1,235,469
|
||||||||||||||||||||
Gregory
A. Fraser
|
37,600
|
11.97
|
19.38
|
19.38
|
12/05/2015
|
458,268
|
1,161,341
|
||||||||||||||||||||
Barbara
R. Smith
|
30,000
|
9.55
|
19.38
|
19.38
|
12/05/2015
|
365,639
|
926,602
|
||||||||||||||||||||
39,000
|
12.42
|
26.68
|
26.68
|
02/21/2015
|
654,397 |
1,658,321
|
Name
|
Number
of
Shares
Acquired
on
Exercise
|
Value
Realized ($)
|
Number
of
Unexercised
Options/
SARs
At
FY-End
(#)
|
Value
of
Unexercised
In-the-Money
Options/SARs
at
FY-End
($)(1)
|
||||||||||||
Exercisable
|
Unexercisable
|
|||||||||||||||
Simon
Raab (2)
|
-
|
-
|
90,000
|
$
|
1,599,300
|
--
|
||||||||||
Jay
Freeland (3)
|
-
|
-
|
90,000
|
$
|
24,800
|
--
|
||||||||||
Barbara
R. Smith (4)
|
-
|
-
|
69,000
|
$
|
18,600
|
--
|
||||||||||
Gregory
A. Fraser (5)
|
-
|
-
|
97,600
|
$
|
1,093,712
|
--
|
(1)
|
Based
on the closing price of $20.00 per share of the Company’s Common Stock on
December 30, 2005 as quoted on The Nasdaq Stock Market.
|
(2)
|
The
90,000 stock option held by Mr. Raab that was granted on May 29,
2002,
expiring on May 29, 2012, is exercisable.
|
(3)
|
The
stock options held by Mr. Freeland include a 50,000 stock option
which was
granted on November 15, 2005, expiring on November 15, 2015, that
is
currently exercisable and the 40,000 stock option which was granted
on
December 5, 2005, expiring on December 5, 2015, that is currently
exercisable.
|
(4)
|
The
stock options held by Ms. Smith include a 39,000 stock option which
was
granted on February 21, 2005, expiring on February 21, 2015, that
is
currently exercisable; and the 30,000 stock option which was granted
on
December 5, 2005, expiring on December 5, 2015, that is currently
exercisable
|
(5)
|
The
stock options held by Mr. Fraser include a 60,000 stock option which
was
granted on May 27, 2002, expiring on May 27, 2012, is currently
exercisable; and the 37,600 stock option which was granted on December
5,
2005, expiring on December 5, 2015, is currently
exercisable.
|
Plan
Category
|
Number
of Securities To be Issued upon Exercise of Outstanding Options,
Warrants,
and Rights
|
Weighted
Average Exercise Price of Outstanding Options, Warrants, and
Rights
|
Number
of Securities Remaining Available for Future
Issuance
|
|||||||
Equity
compensation plans approved by security holders
|
1,340,034
|
$
|
16.72
|
803,591
|
||||||
Equity
compensation plans not approved by security holders
|
—
|
—
|
—
|
|||||||
Total
|
1,340,034
|
$
|
16.72
|
803,591
|
·
|
a
“pay-for-performance” feature that differentiates compensation results
based upon organizational results and overall performance against
plan;
and
|
·
|
stock
incentives, in certain cases, as a component of total compensation
in
order to closely align the interests of the Company’s executives with the
long-term interests of shareholders which facilitates retention of
talented executives and encourages Company stock ownership and capital
accumulation; and emphasis on total compensation vs. cash compensation,
under which base salaries are generally set competitive levels in
order to
motivate and reward Company executives with total compensation (including
incentive programs) at or above competitive levels, if the financial
performance of the Company meets or exceeds goals established for
the
year.
|
July
28, 2006
|
Compensation
Committee
|
Stephen
Cole (Chair)
|
|
Hubert
d’Amours
|
|
Andre
Julien
|
|
Norman
Schipper
|
|
Date
|
FARO
|
Dow
|
DowElec.Equip.
|
|||||||
31-Dec-00
|
$
|
100.00
|
$
|
100.00
|
$
|
100.00
|
||||
31-Dec-01
|
$
|
74.67
|
$
|
88.05
|
$
|
53.44
|
||||
31-Dec-02
|
$
|
63.00
|
$
|
68.61
|
$
|
36.84
|
||||
31-Dec-03
|
$
|
832.67
|
$
|
89.70
|
$
|
55.37
|
||||
31-Dec-04
|
$
|
1,039.33
|
$
|
100.48
|
$
|
60.07
|
||||
31-Dec-05
|
$
|
666.67
|
$
|
106.84
|
$
|
64.67
|
2004
|
2005
|
||||||
Audit
fees (1)
|
$
|
770,000
|
$
|
976,868
|
|||
Audit
related fees
|
-
|
-
|
|||||
Tax
fees-preparation and compliance
|
-
|
-
|
|||||
Total
audit, audit related and tax preparation and
compliance
fees
|
770,000
|
976,868
|
|||||
Other
non-audit fees
(2)
|
32,100
|
||||||
Tax
fees-other
|
-
|
-
|
|||||
All
other fees
|
-
|
-
|
|||||
Total
other fees
|
-
|
-
|
|||||
Total
fees
|
$
|
770,000
|
$
|
1,008,968
|
(1)
|
Audit
of financial statements, review of financial statements included
in
Quarterly Reports on Form 10-Q, and audit of management’s assessment of
the Company’s internal control over financial reporting and the
effectiveness of the Company’s internal control over financial reporting.
|
|||||||||||
(2)
|
Primarily
fees in connection with the Company’s employee benefit plan audit and Form
S-3 registration statement (File No.
333-110670).
|
|
|
|
|
By
Order of the Board of Directors
|
|
|
|
|
|
August
10, 2006
|
|
|
|
GREGORY
A. FRASER, Ph.D.
Executive
Vice President
|
· | The Committee shall be comprised of three or more directors as determined by the Board |
·
|
All
members of the Committee shall meet the general independence, experience
and financial understanding requirements of the Nasdaq Stock Market,
Inc.
(“Nasdaq”), Section 10A(m)(3) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and the rules and regulations of the
Securities and Exchange Commission (the
“SEC”)
|
·
|
At
least one member of the Committee shall be an “audit committee financial
expert” as defined by the SEC
|
·
|
The
Committee shall meet as frequently as circumstances dictate (but
not less
frequently than quarterly).
|
·
|
The
Committee shall meet periodically in executive session with management
(including the chief financial officer and chief accounting officer),
the
internal audit staff and the independent auditor and shall have such
other
direct and independent interaction with such persons from time to
time as
the members of the Committee deem
appropriate
|
·
|
The
Committee may request any officer or employee of the Company or the
Company’s outside counsel or independent auditor to attend a meeting of
the Committee or to meet with any members of, or consultants to,
the
Committee.
|
·
|
The
members of the Committee shall be appointed by the Board annually
or as
necessary to fill vacancies on the recommendation of the Company’s
Nominating and Corporate Governance Committee (or, in the absence
of such
a committee, the full Board)
|
·
|
The
Chairperson of the Committee shall be appointed by the Board upon
recommendation of the Nominating and Corporate Governance Committee
and in
consultation with the Chairman of the Board (or, in the absence of
such a
committee, the full Board)
|
·
|
The
Chairperson will chair all regular sessions of the Committee and,
in
consultation with the Company’s management, set the agenda for Committee
meetings; provided that in the Chairperson’s absence, the Chairperson’s
responsibilities may be undertaken by another member of the
Committee
|
·
|
Any
member of the Committee may call meetings of the
Committee
|
·
|
Review
and reassess the adequacy of this Charter annually, with the assistance
of
counsel, if appropriate, with an emphasis on compliance with any
new SEC
or Nasdaq rules and considering other developments as
appropriate
|
·
|
Submit
the Charter to the Board for approval annually and have the Charter
published in the Company’s proxy statement at least every three years or
as otherwise appropriate in accordance with the SEC’s rules and
regulations
|
·
|
Discuss
with management its efforts to communicate the importance of internal
control
|
·
|
Discuss
annually with management and the external auditors the extent to
which the
external auditors review computer systems and applications, the security
of such systems and applications, and the contingency plan for processing
financial information in the event of a systems breakdown; advise
the
Board of, or otherwise address, any significant issues or
recommendations
|
·
|
Determine
by discussion with management whether internal control recommendations
made by the external auditors have been implemented by management;
request
that, in connection with the Company’s next financial statement audit, the
external auditors advise the Committee of whether the recommendations
were
implemented to the satisfaction of the external
auditors
|
·
|
Review
disclosures made to the Committee by the Company’s Chief Executive Officer
and Chief Financial Officer during their certification process for
the
Form 10-K and Form 10-Q about any significant deficiencies in the
design or operation of internal controls or material weaknesses therein
and any fraud involving management or other employees who have a
significant role in the Company’s internal
controls.
|
·
|
Request
that management and/or the Company’s or the Committee’s outside experts
periodically update the Committee about significant accounting and
reporting issues, including recent professional and regulatory
pronouncements
|
·
|
At
least annually, ask management and the external auditors about significant
risks and exposures and the plans to minimize such risks; request
that
management and the external auditors provide updates to the Committee
as
appropriate
|
·
|
Review
major changes to the Company’s accounting principles as suggested by the
external auditors or management
|
·
|
Review
and discuss with management and the external auditors the quarterly
and
annual earnings press releases; provided that the responsibility
for such
review may be delegated to one or more members of the
Committee
|
·
|
Review
and discuss with management and the external auditors the annual
audited
financial statements to be included in the Company’s annual report on Form
10-K; and, based on the foregoing review and discussion, recommend
to the
Board whether the audited financial statements should be included
in the
Company’s Form 10-K
|
·
|
Review
and discuss with management and the external auditors the management’s
discussion and analysis (“MD&A”) and other sections of the annual
report before its release
|
·
|
Consult
with management and the external auditors, as appropriate, regarding
matters related to the preparation of quarterly financial
information
|
·
|
Review
and discuss with management the interim financial statements and
MD&A
included in each quarterly Form 10-Q prior to filing thereof with
the SEC;
provided that the responsibility for such review may be delegated
to one
or more members of the Committee
|
·
|
All
critical accounting policies and practices to be
used
|
·
|
All
alternative treatments of financial information within generally
accepted
accounting principles that have been discussed with management,
ramifications of the use of such alternative disclosures and treatments,
and the treatment preferred by the external
auditors
|
·
|
Other
material written communications between the external auditors and
management, such as any management letter or schedule of
unadjusted differences
|